Clinical Trial Update: Pre-genotype NUDT 15 R139C on Reducing Thiopurine-induced Leucopenia in Inflammatory Bowel Disease [NA]

View source ↗

Summary

This clinical trial update describes evaluating pre-genotyping the NUDT15 R139C variant as a strategy to reduce thiopurine-induced leucopenia in inflammatory bo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Thiopurine-induced Leukopenia | NA | Status: UNKNOWN